Quadrant Capital Group’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-13,249
| Closed | -$23.3K | – | 2764 |
|
|
2023
Q1 | $23.3K | Buy |
13,249
+515
| +4% | +$906 | ﹤0.01% | 1623 |
|
|
2022
Q4 | $40K | Buy |
12,734
+11,392
| +849% | +$35.8K | ﹤0.01% | 1301 |
|
|
2022
Q3 | $7K | Sell |
1,342
-2,550
| -66% | -$13.3K | ﹤0.01% | 2033 |
|
|
2022
Q2 | $16K | Buy |
3,892
+3,729
| +2,288% | +$15.3K | ﹤0.01% | 1423 |
|
|
2022
Q1 | $1K | Buy |
+163
| New | +$1K | ﹤0.01% | 2384 |
|
|
2020
Q2 | – | Sell |
-89
| Closed | – | – | 2377 |
|
|
2020
Q1 | $0 | Buy |
89
+30
| +51% | – | ﹤0.01% | 2248 |
|
|
2019
Q4 | $0 | Hold |
59
| – | – | ﹤0.01% | 2481 |
|
|
2019
Q3 | $0 | Hold |
59
| – | – | ﹤0.01% | 2377 |
|
|
2019
Q2 | $0 | Hold |
59
| – | – | ﹤0.01% | 2391 |
|
|
2019
Q1 | $0 | Hold |
59
| – | – | ﹤0.01% | 2326 |
|
|
2018
Q4 | $0 | Hold |
59
| – | – | ﹤0.01% | 2281 |
|
|
2018
Q3 | $1K | Hold |
59
| – | – | ﹤0.01% | 2037 |
|
|
2018
Q2 | $0 | Sell |
59
-455
| -89% | – | ﹤0.01% | 2195 |
|
|
2018
Q1 | $9K | Hold |
514
| – | – | ﹤0.01% | 1317 |
|
|
2017
Q4 | $8K | Hold |
514
| – | – | ﹤0.01% | 1292 |
|
|
2017
Q3 | $7K | Hold |
514
| – | – | ﹤0.01% | 1345 |
|
|
2017
Q2 | $4K | Hold |
514
| – | – | ﹤0.01% | 1431 |
|
|
2017
Q1 | $2K | Buy |
+514
| New | +$2K | ﹤0.01% | 1652 |
|